Spots Global Cancer Trial Database for microspheres
Every month we try and update this database with for microspheres cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver | NCT01098422 | Colorectal Neop... Liver Neoplasms | Yttrium-90 Radi... | 18 Years - | University of California, San Diego | |
| Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors | NCT02975739 | Radioisotopes Head and Neck N... | Holmium-166 (po... | 18 Years - | UMC Utrecht | |
| Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors | NCT02975739 | Radioisotopes Head and Neck N... | Holmium-166 (po... | 18 Years - | UMC Utrecht | |
| Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease | NCT01864070 | Liver Cancer | TheraSphere Everolimus Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver | NCT01098422 | Colorectal Neop... Liver Neoplasms | Yttrium-90 Radi... | 18 Years - | University of California, San Diego | |
| Uterine Artery Embolization With Microspheres in Patients With Leiomyoma. | NCT03535610 | Uterine Leiomyo... | Uterine Emboliz... | 18 Years - 50 Years | Scitech Produtos Medicos Ltda | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device | NCT06192758 | Prostate Cancer | TheraSphere PCa | 50 Years - | Boston Scientific Corporation | |
| First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device | NCT06192758 | Prostate Cancer | TheraSphere PCa | 50 Years - | Boston Scientific Corporation | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC | NCT06190665 | Hepatocellular ... | DEB-TACE with v... DEB-TACE with P... | 18 Years - 80 Years | Zhongda Hospital | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease | NCT01864070 | Liver Cancer | TheraSphere Everolimus Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
